Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;17(2):97-113.
doi: 10.1038/nrd.2017.232. Epub 2017 Dec 15.

Automating Drug Discovery

Affiliations
Review

Automating Drug Discovery

Gisbert Schneider. Nat Rev Drug Discov. .

Abstract

Small-molecule drug discovery can be viewed as a challenging multidimensional problem in which various characteristics of compounds - including efficacy, pharmacokinetics and safety - need to be optimized in parallel to provide drug candidates. Recent advances in areas such as microfluidics-assisted chemical synthesis and biological testing, as well as artificial intelligence systems that improve a design hypothesis through feedback analysis, are now providing a basis for the introduction of greater automation into aspects of this process. This could potentially accelerate time frames for compound discovery and optimization and enable more effective searches of chemical space. However, such approaches also raise considerable conceptual, technical and organizational challenges, as well as scepticism about the current hype around them. This article aims to identify the approaches and technologies that could be implemented robustly by medicinal chemists in the near future and to critically analyse the opportunities and challenges for their more widespread application.

Similar articles

See all similar articles

Cited by 24 articles

See all "Cited by" articles

References

    1. J Chem Inf Model. 2016 Feb 22;56(2):286-99 - PubMed
    1. Acc Chem Res. 2008 Jan;41(1):40-9 - PubMed
    1. Comput Appl Biosci. 1994 Dec;10(6):635-45 - PubMed
    1. J Med Chem. 1998 Aug 27;41(18):3314-24 - PubMed
    1. J Lab Autom. 2016 Feb;21(1):49-56 - PubMed

Publication types

Substances

LinkOut - more resources

Feedback